share_log

Craig-Hallum Initiates Coverage On ScPharmaceuticals With Buy Rating, Announces Price Target of $20

Craig-Hallum Initiates Coverage On ScPharmaceuticals With Buy Rating, Announces Price Target of $20

Craig-Hallum以买入评级开始对SCPharmicals进行报道,宣布目标股价为20美元
Benzinga ·  2023/09/07 08:48

Craig-Hallum analyst Chase Knickerbocker initiates coverage on scPharmaceuticals (NASDAQ:SCPH) with a Buy rating and announces Price Target of $20.

克雷格-哈勒姆分析师大通·尼克博克在纳斯达克(Sequoia PharmPharmticals)(Sequoia PharmPharmticals:SCPH)上启动了买入评级,并宣布目标价为20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发